investor_presentation
F.N.B. Corporation
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Moderna's 2022 Annual R&D Day presentation covering the company's mRNA science platform and pipeline developments. The deck outlines upcoming clinical trial timelines for vaccine and therapeutic candidates targeting infectious diseases and rare genetic disorders, including programs in RSV, CMV, PCV, and combination vaccines.
conference
25 Pages
investor_presentation
18 Pages
Delta Air Lines
Regeneron Pharmaceuticals Investor Presentation — February 2021
investor_presentationinvestor_presentation
28 Pages
Regeneron Pharmaceuticals, Inc.
investor_presentation
F.N.B. Corporation